Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: A national cross-sectional cohort study

BMC Pulmonary Medicine

Volumn 13, Issue 1, 2013, Pages

  Kim, Jinhee ^a   Lee, Jin Hwa ^b   Kim, Yuri ^c   Kim, Kyungjoo ^c   Oh, Yeon Mok ^d   Yoo, Kwang Ha ^e   Rhee, Chin Kook ^f   Yoon, Hyoung Kyu ^g   Kim, Young Sam ^h   Park, Yong Bum ⁱ   Lee, Sei Won ^d   Lee, Sang Do ^d  

^a National Evidence Based Healthcare Collaborating Agency   (South Korea)

^b Ewha Womans University School of Medicine   (South Korea)

^c National Strategic Coordinating Center for Clinical Research   (South Korea)

^d University of Ulsan College of Medicine   (South Korea)

^e Konkuk University School of Medicine   (South Korea)

^f The Catholic University of Korea   (South Korea)

^g The Catholic University of Korea   (South Korea)

^h Yonsei University College of Medicine   (South Korea)

ⁱ Hallym University   (South Korea)

Author keywords

Anticholinergic; Exacerbation; Gastroesophageal reflux; Obstructive lung disease; Prevalence

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; THEOPHYLLINE;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; RISK FACTOR; ADULT; AGE; AGED; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; SEX DIFFERENCE; SOUTH KOREA; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; REPUBLIC OF KOREA; RISK FACTORS; SEX FACTORS;

EID: 84881131393     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-13-51     Document Type: Article

References (33)

1. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57(10):847-852. 10.1136/thorax.57.10.847, 1746193, 12324669.
2. Soler-Cataluña JJ, Martínez-García MA, Román Sánchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005, 60(11):925-931. 10.1136/thx.2005.040527, 1747235, 16055622.
3. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Global strategy for diagnosis, management, and prevention of COPD http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Date last updated: February 2013. Date last accessed: July 12 2012, Global Initiative for Chronic Obstructive Lung Disease (GOLD).
4. Pratter MR. Overview of common causes of chronic cough: ACCP evidence-based clinical practice guidelines. Chest 2006, 129(Suppl):59-62.
5. Hurst JR, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, Miller B, Lomas DA, Agusti A, Macnee W, Calverley P, Rennard S, Wouters EF, Wedzicha JA, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 363(12):1128-1138. 10.1056/NEJMoa0909883, 20843247, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.
6. Rascon-Aguilar IE, Pamer M, Wludyka P, Cury J, Coultas D, Lambiase LR, Nahman NS, Vega KJ. Role of gastroesophageal reflux symptoms in exacerbations of COPD. Chest 2006, 130(4):1096-1101. 10.1378/chest.130.4.1096, 17035443.
7. Terada K, Muro S, Sato S, Ohara T, Haruna A, Marumo S, Kinose D, Ogawa E, Hoshino Y, Niimi A, Terada T, Mishima M. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. Thorax 2008, 63(11):951-955. 10.1136/thx.2007.092858, 18535116.
8. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systemic review. Gut 2005, 54(5):710-717. 10.1136/gut.2004.051821, 1774487, 15831922.
9. Jung HK. Epidemiology of gastresophageal reflux disease in Asia: a systematic review. J Neurogastroenterol Motil 2011, 17(1):14-27. 10.5056/jnm.2011.17.1.14, 3042214, 21369488.
10. Field SK, Evans JA, Price LM. The effects of acid perfusion of the esophagus on ventilation and respiratory sensation. Am J Respir Crit Care Med 1998, 157(4):1058-1062. 10.1164/ajrccm.157.4.9707094, 9563719.
11. Cuttitta G, Cibella F, Visconti A, Scichilone N, Bellia V, Bonsignore G. Spontaneous gastresophageal reflux and airway patency during the night in adult asthmatics. Am J Respir Crit Care Med 2000, 161(1):177-181. 10.1164/ajrccm.161.1.9808014, 10619817.
12. Alexander JA, Hunt LW, Patel AM. Prevalence, pathophysiology, and treatment of patients with asthma and gastresophageal reflux disease. Mayo Clin Proc 2000, 75(10):1055-1063. 10.4065/75.10.1055, 11040853.
13. Phua SY, McGarvey LP, Ngu MC, Ing AJ. Patients with gastro-oesophageal reflux disease and cough have impaired laryngopharyngeal mechanosensitivity. Thorax 2005, 60(6):488-491. 10.1136/thx.2004.033894, 1747421, 15923249.
14. Sontag SJ, O'Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell TG, Serlovsky R. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 1990, 99(3):613-620.
15. Savarino E, Bazzica M, Zentilin P, Pohl D, Parodi A, Cittadini G, Negrini S, Indiveri F, Tutuian R, Savarino V, Ghio M. Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 2009, 179(5):408-413. 10.1164/rccm.200808-1359OC, 19096004.
16. Sweet MP, Patti MG, Hoopes C, Hays SR, Golden JA. Gastro-oesophageal reflux and aspiration in patients with advanced lung disease. Thorax 2009, 64(2):167-173. 10.1136/thx.2007.082719, 19176842.
17. Pauwels A, Blondeau K, Dupont LJ, Sifrim D. Mechanisms of increased gastroesophageal reflux in patients with cystic fibrosis. Am J Gastroenterol 2012, 107(9):1346-1353. 10.1038/ajg.2012.213, 22777342.
18. Stein MR, Towner TG, Weber RW, Mansfield LE, Jacobson KW, McDonnell JT, Nelson HS. The effect of theophylline on the lower esophageal sphincter pressure. Ann Allergy 1980, 45(4):238-241.
19. Crowell MD, Zayat EN, Lacy BE, Schettler-Duncan A, Liu MC. The effects of an inhaled beta(2)-adrenergic agonist on lower esophageal function: a dose-response study. Chest 2001, 120(4):1184-1189. 10.1378/chest.120.4.1184, 11591558.
20. Mokhlesi B, Morris AL, Huang CF, Curcio AJ, Barrett TA, Kamp DW. Increased prevalence of gastresophageal reflux symptoms in patients with COPD. Chest 2001, 119(4):1043-1048. 10.1378/chest.119.4.1043, 11296167.
21. Casanova C, Baudet JS, del Valle VM, Martin JM, Aguirre-Jaime A, de Torres JP, Celli BR. Increased gastro-oesophageal reflux disease in patients with severe COPD. Eur Respir J 2004, 23(6):841-845. 10.1183/09031936.04.00107004, 15218995.
22. García Rodríguez LA, Ruigómez A, Martín-Merino E, Johansson S, Wallander MA. Relationship between gastresophageal reflux disease and COPD in UK primary care. Chest 2008, 134(6):1223-1230. 10.1378/chest.08-0902, 18689591.
23. Rogha M, Behravesh B, Pourmoghaddas Z. Association of gastresophageal reflux disease symptoms with exacerbations of chronic obstructive pulmonary disease. J Gastrointestin Liver Dis 2010, 19(3):253-256.
24. Takada K, Matsumoto S, Kojima E, Iwata S, Okachi S, Ninomiya K, Morioka H, Tanaka K, Enomoto Y. Prospective evaluation of the relationship between acute exacerbations of COPD and gastroesophageal reflux disease diagnosed by questionnaire. Respir Med 2011, 105(10):1531-1536. 10.1016/j.rmed.2011.03.009, 21454063.
25. Braman SS. Chronic cough due to chronic bronchitis: ACCP evidence-based clinical practice guidelines. Chest 2006, 129(1 Suppl):104-115.
26. Molassiotis A, Bryan G, Caress A, Bailey C, Smith J. Pharmacological and non-pharmacological interventions for cough in adults with respiratory and non-respiratory diseases: a systematic review of the literature. Respir Med 2010, 104(7):934-944. 10.1016/j.rmed.2010.02.010, 20385478.
27. Lowry R, Wood A, Higenbottam T. The effect of anticholinergic bronchodilator therapy on cough during upper respiratory tract infections. Br J Clin Pharmacol 1994, 37(2):187-191. 10.1111/j.1365-2125.1994.tb04259.x, 1364596, 8186064.
28. Dicpinigaitis PV, Spinner L, Santhyadka G, Negassa A. Effect of tiotropium on cough reflex sensitivity in acute viral cough. Lung 2008, 186(6):369-374. 10.1007/s00408-008-9114-6, 18787899.
29. Cui Y, Devillier P, Kuang X, Wang H, Zhu L, Xu Z, Xia Z, Zemoura L, Advenier C, Chen H. Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux. Eur Respir J 2010, 35(6):1370-1376. 10.1183/09031936.00139909, 19926736.
30. Nelson HS, Weiss ST, Bleecker ER, Yancey SW, Dorinsky PM, SMART Study Group The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 2006, 129(1):15-26. 10.1378/chest.129.1.15, 16424409, SMART Study Group.
31. Poe RH, Kallay MC. Chronic cough and gastresophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 2003, 123(3):679-684. 10.1378/chest.123.3.679, 12628862.
32. Sasaki T, Nakayama K, Yasuda H, Yoshida M, Asamura T, Ohrui T, Arai H, Araya J, Kuwano K, Yamaya M. A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. J Am Geriatr Soc 2009, 57(8):1453-1457. 10.1111/j.1532-5415.2009.02349.x, 19515110.
33. Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010, 11:122. 2944278, 20831787, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) investigators.